Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.

about

Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.

Item

http://www.wikidata.org/entity/Q47106697

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.

@en

Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.

@nl

type

Item

label

Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.

@en

Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.

@nl

prefLabel

Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.

@en

Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.

@nl

P1476

Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.

@en

P2093

Irfan Zaidi

http://www.w3.org/2001/XMLSchema#string

Justin Yai Alamou Doritchamou

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies

Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230.

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

Cross-species malaria immunity induced by chemically attenuated parasites.

Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria.

P2888

s41541-017-0035-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1038/S41541-017-0035-3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Camila Henriques Coelho

Patrick E. Duffy

P577

2017-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29522056

http://www.w3.org/2001/XMLSchema#string

P921

malaria

P932

5709382

http://www.w3.org/2001/XMLSchema#string